AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

In a different context, a comparative analysis in Tanzania evaluated percutaneous drainage against surgical drainage for intra-abdominal abscesses. The findings indicated that percutaneous ...

Abscesses can occur anywhere in the body, including inside the abdominal cavity. They involve a pocket of pus developing after infection. In many cases, abdominal abscesses develop after surgical ...

Background Laparoscopic appendectomy is not yet unanimously considered the "gold standard" in the treatment of acute appendicitis because of its higher operative time, intra-abdominal abscess risk ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...